Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes.
about
Antioxidants in Cardiovascular Therapy: Panacea or False Hope?Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingImproved oxidative status in major abdominal surgery patients after N-acetyl cystein supplementationMolecular strategies for targeting antioxidants to mitochondria: therapeutic implications.Inflammatory and antioxidant pattern unbalance in "clopidogrel-resistant" patients during acute coronary syndromeIncreased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats.N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.N-acetylcysteine supplementation decreases osteoclast differentiation and increases bone mass in mice fed a high-fat diet.Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality.Platelet hyperaggregability in high-fat fed rats: a role for intraplatelet reactive-oxygen species production.Effects of N-acetylcysteine on the cardiac remodeling biomarkers and major adverse events following acute myocardial infarction: a randomized clinical trial.Oxidative Stress Regulation on Endothelial Cells by Hydrophilic Astaxanthin Complex: Chemical, Biological, and Molecular Antioxidant Activity Evaluation.Targeting oxidative stress through antioxidants in diabetes mellitus.
P2860
Q26776115-FDBBDFA3-DCBC-4DF2-BEFB-12C1823F5D6BQ28389739-85124663-1C30-4197-8FBA-81AA26B72274Q35060309-0F024553-DD89-4734-A4C2-B2723B673FAEQ35148462-68F85495-6F83-48BC-9ADC-638EBD963128Q35250401-2FD717FA-F25E-4B83-A735-81031F00E28EQ35975176-28B1EA6C-509D-4727-8CAA-8A25DC595425Q36297823-776B6AEB-2A55-49B9-857B-9F53010C47A9Q38084184-83479879-2B1E-4FAB-8E24-8AE8000BECD2Q39037991-08208014-DA9E-4EA4-A2C3-E673F9E019C8Q42355197-BF682853-B975-4A27-831A-8227BD7CBB02Q42555438-84C80450-204E-4463-BE5D-CF6AF5DDBA12Q43502186-F4246692-F1AF-4081-8933-132A61474E02Q46271180-33C12BC4-D2B1-4F20-8158-301007FDA72DQ47235697-2027BA77-B7CC-4F9D-B859-5719C6857F98
P2860
Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Therapeutic potential of N-ace ...... patients with type-2 diabetes.
@ast
Therapeutic potential of N-ace ...... patients with type-2 diabetes.
@en
type
label
Therapeutic potential of N-ace ...... patients with type-2 diabetes.
@ast
Therapeutic potential of N-ace ...... patients with type-2 diabetes.
@en
prefLabel
Therapeutic potential of N-ace ...... patients with type-2 diabetes.
@ast
Therapeutic potential of N-ace ...... patients with type-2 diabetes.
@en
P2093
P2860
P356
P1476
Therapeutic potential of N-ace ...... patients with type-2 diabetes.
@en
P2093
Fiona Barrett
Kyle R Gibson
Sandra M MacRury
Sushma Sharma
Tim J Winterburn
P2860
P2888
P356
10.1186/1475-2840-10-43
P407
P50
P577
2011-05-21T00:00:00Z
P5875
P6179
1018854935